metricas
covid
Buscar en
Revista Colombiana de Reumatología (English Edition)
Toda la web
Inicio Revista Colombiana de Reumatología (English Edition) Splenic infarction as presentation of antiphospholipid syndrome and systemic lup...
Journal Information
Vol. 31. Issue 1.
Pages 127-132 (January - March 2024)
Share
Share
Download PDF
More article options
Visits
44
Vol. 31. Issue 1.
Pages 127-132 (January - March 2024)
Case report
Splenic infarction as presentation of antiphospholipid syndrome and systemic lupus erythematosus: A case report
Infarto esplénico como presentación del síndrome antifosfolipídico y lupus eritematoso sistémico: Reporte de un caso
Visits
44
Johan Azañero-Haroa,b,
Corresponding author
johan1675@gmail.com

Corresponding author.
, Liliana Chambia,b, Alonso Sotoa,c
a Departamento de Medicina Interna, Hospital Nacional Hipólito Unánue, Lima, Peru
b Escuela de Postgrado, Universidad Científica del Sur, Lima, Peru
c Instituto de Investigaciones en Ciencias Biomédicas (INICIB), Facultad de Medicina, Universidad Ricardo Palma, Lima, Peru
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (2)
Table 1. Blood analysis.
Table 2. Diagnostic criteria for antiphospholipid syndrome.
Show moreShow less
Abstract

Splenic infarction is a rare condition usually associated with systemic conditions. Antiphospholipid syndrome (APS) is an autoimmune condition that can present as abdominal pain due to splenic infarction. We describe a patient with systemic lupus erythematosus, admitted due to acute abdominal pain. Abdominal CT scan showed splenic infarction, and tests for antiphospholipid and anti-β2-glycoprotein I antibodies were positive. The pathophysiology and clinical presentation of splenic infarction associated with APS is discussed, emphasizing the importance of including this entity in the differential diagnosis of abdominal pain of uncertain cause in patients with systemic conditions.

Keywords:
Splenic infarction
Abdominal pain
Systemic lupus erythematosus
Antiphospholipid syndrome
Antiphospholipid antibodies
Resumen

El infarto esplénico es una condición infrecuente, generalmente asociada con afecciones sistémicas. El síndrome antifosfolipídico (SAF) es una enfermedad autoinmune que puede presentarse como dolor abdominal debido a infarto esplénico. Se describe el caso de una paciente con lupus eritematoso sistémico que ingresó con dolor abdominal agudo. La tomografía abdominal evidenció infarto esplénico y las pruebas de laboratorio para anticuerpos antifosfolípidos y anti-β2-glicoproteína I fueron positivas. Se discute la fisiopatología y la presentación clínica del infarto esplénico asociado con SAF, enfatizando la importancia de incluir esta entidad en el diagnóstico diferencial del dolor abdominal de causa incierta en pacientes con afecciones sistémicas.

Palabras clave:
Infarto esplénico
Dolor abdominal
Lupus eritematoso sistémico
Síndrome antifosfolipídico
Anticuerpos antifosfolípidos

Article

These are the options to access the full texts of the publication Revista Colombiana de Reumatología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Quizás le interese:
10.1016/j.rcreue.2023.03.001
No mostrar más